NEWFlashcards for any set of questions, quick-reference tables for breast, lung and prostate, and a month of access for every colleague you refer. See what changed

Lung: Extensive-stage SCLC - PCI

Free question published 13 September 2026

RespiratoryExtensive-stage SCLC - PCI

A 67-year-old woman with extensive-stage small-cell lung cancer has had a good response to first-line platinum-etoposide chemotherapy, with no brain metastases on staging MRI and WHO performance status 1. Which statement reflects current UK guidance on prophylactic cranial irradiation for her?

  1. AConsider prophylactic cranial irradiation, as her disease has responded and her performance status is 0 to 2
  2. BOffer prophylactic cranial irradiation 25 Gy in 10 fractions, as her disease has not progressed on first-line treatment
  3. COffer prophylactic cranial irradiation only after thoracic consolidation radiotherapy has been completed
  4. DConsider prophylactic cranial irradiation only where MRI brain surveillance is unavailable
  5. EDo not offer prophylactic cranial irradiation, as it has no role in extensive-stage disease

Why A is correct

NICE NG122 advises that prophylactic cranial irradiation should be considered for people with extensive-stage small-cell lung cancer and WHO performance status 0 to 2 if their disease has responded to first-line treatment. The wording is consider, a weaker recommendation than the offer used for limited-stage disease, reflecting the more contested evidence in the MRI surveillance era; the limited-stage recommendation specifies 25 Gy in 10 fractions for disease that has not progressed.

And why the others are not

  • BIncorrect: this is the limited-stage recommendation (offer, 25 Gy in 10 fractions, disease not progressed); extensive-stage disease carries the weaker consider wording.
  • CIncorrect: NICE does not sequence prophylactic cranial irradiation after thoracic consolidation, which is a separate consideration.
  • DIncorrect: NICE does not condition prophylactic cranial irradiation on the unavailability of MRI surveillance.
  • EIncorrect: prophylactic cranial irradiation is not excluded in extensive-stage disease; it is a considered option in responders.

Source NICE NG122 - Lung cancer: diagnosis and management — National Institute for Health and Care Excellence. Lung cancer: diagnosis and management. NICE guideline NG122. Published 28 March 2019, last updated 08 March 2024.

More free respiratory questions

Sitting in February? Follow the twenty-week plan.

2,500+ cited questions like this one are waiting in the vault.

See plans and pricing